alexa Whole Genome Methodology For In Silico Quantification Of Intratumor Heterogeneity: Model For Clinical Applications In The Treatment Of Patients With Hematological Malignancies
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Hematology & Blood Disorders
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Effie Liakopoulou and Daniel Bozinov
ScientificTracks Abstracts: J Blood Disorders Transf
DOI: 10.4172/2155-9864.S1.006
Abstract
The genomic revolution provides an unprecedented opportunity to revolutionize cancer treatment, however our current approaches cannot fully capitalize on the latest scientific discoveries. Conventional treatment ignores the fundamental lesson of genomics-that every cancer is different. There are many challenges of scientific and technical nature. Elucidating the general operating mechanisms of cancer requires tools for converting the results of omic testing into candidate networks and monitoring of how these networks respond and evolve with treatment overtime, pointing to candidate vulnerabilities.A profile of a patient?s genetic make up can guide the selection of drugs or treatment protocols that ensure targeted, successful outcome and minimize harmful side effects. In addition intratumor heterogeneity constitutes a fundamental mechanism in drug resistant recurrences of malignant neoplasms. Third Gen Sequencing technologies provide the necessary throughput, precision, and depth to allow for true whole genome profiling of complex mutomes. An in silico methodology to quantify and visualize sub-clonal heterogeneity in aggressive tumors through massively parallel processing, real-time 3D rendering, and cognitive computation have been set and described. Our novel comprehensive service platform provides an analytical turnaround within a clinically relevant time frame to facilitate diagnostic, therapeuticand prognostic guidance to oncologists. Hematological malignancies are paradigms for pioneering the use and the benefits of this platform with consequent applications in the wider field of oncology.
Biography
Effie Liakopoulou is a physician scientist, specialist in Hematology Stem Cell Transplantation with particular interests in Hematological Oncology, Cell Therapies and Personalized Medicine. She holds MD and PhD degrees and a Certificate in Medical Management. She has 21 years of international experience and sound knowledge of the landscape in science, research and technology on clinical, medical and regulatory matters. Since 2006 she has served as inspector for the Joint Accreditation Committee - International Society for Cellular Therapy & European Group for Blood and Marrow Transplantation performing audits and due diligence of clinical, laboratory, research and specialist stem cell facilities. She is a member of several international professional organizations, and in 2009 she was elected Fellow of the Royal College of Pathologists, UK, in recognition of her contributions to the field of Hematology. She has co-authored several peer-reviewed publications and articles. Currently, she is an Affiliate Faculty Member in Hematology at, UW Medicine and Senior Research role for Retroscreen LTD. She is leading the coordination of due diligence in the academic, biotechnology and pharmaceutical arenas for technologies and fostering alliances for the advancement of Cancer therapies, Medicine and Health care as a whole.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords